| Period Ending | Mar 31, 2013 | Dec 31, 2012 | Mar 31, 2012 | Dec 31, 2011 |
|---|
|
Total Revenue
|
19,090,000
|
18,409,000
|
21,215,000
|
22,525,000
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
-
|
-
|
-
|
-
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 624,000 | 588,000 | 596,000 | 553,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | (503,000) | (700,000) | 1,825,000 | 2,578,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
-
|
-
|
-
|
-
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 18,969,000 | 18,521,000 | 18,794,000 | 19,394,000 |
|
Interest Expense | 14,423,000 | 15,209,000 | 18,231,000 | 18,813,000 |
|
Income Before Tax | 4,546,000 | 3,312,000 | 563,000 | 581,000 |
|
Income Tax Expense | (35,000) | (1,145,000) | (14,000) | (38,000) |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 4,581,000 | 4,457,000 | 577,000 | 619,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
4,581,000
|
4,457,000
|
577,000
|
619,000
| | Preferred Stock And Other Adjustments | (6,971,000) | (7,635,000) | (1,804,000) | (1,658,000) | | |
Net Income Applicable To Common Shares
|
(2,390,000)
|
(3,178,000)
|
(1,227,000)
|
(1,039,000)
|
|
1.77%